Icatibant.

Suppr

超能文献

作者信息

Dubois Eline A, Cohen Adam F

出版信息

Br J Clin Pharmacol. 2010 May;69(5):425-6. doi: 10.1111/j.1365-2125.2010.03642.x.

DOI:10.1111/j.1365-2125.2010.03642.x

PMID:20573077

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2856042/

Abstract

摘要

相似文献

Icatibant.

Br J Clin Pharmacol. 2010 May;69(5):425-6. doi: 10.1111/j.1365-2125.2010.03642.x.

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73. doi: 10.1177/039463201202500130.

Hereditary angioedema--therapies old and new.

N Engl J Med. 2010 Aug 5;363(6):581-3. doi: 10.1056/NEJMe1006450.

Therapeutic agents for hereditary angioedema.

N Engl J Med. 2011 Jan 6;364(1):85; author reply 86. doi: 10.1056/NEJMc1010085.

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.

J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1671-1678.e2. doi: 10.1016/j.jaip.2017.04.010. Epub 2017 Jun 7.

Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.

Immun Inflamm Dis. 2017 Jan 11;5(1):29-36. doi: 10.1002/iid3.137. eCollection 2017 Mar.

Icatibant as acute treatment for hereditary angioedema in adults.

Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13.

Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.

Ann Allergy Asthma Immunol. 2016 May;116(5):476-7. doi: 10.1016/j.anai.2016.03.008. Epub 2016 Mar 24.

Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.

Dermatol Ther. 2019 Nov;32(6):e13098. doi: 10.1111/dth.13098. Epub 2019 Oct 28.

First report of icatibant treatment in a pregnant patient with hereditary angioedema.

J Obstet Gynaecol Res. 2016 Aug;42(8):1026-8. doi: 10.1111/jog.13003. Epub 2016 Apr 19.

引用本文的文献

A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema.

J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):721-734. doi: 10.1007/s10928-024-09919-6. Epub 2024 May 11.

Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.

Naunyn Schmiedebergs Arch Pharmacol. 2022 Mar;395(3):275-283. doi: 10.1007/s00210-022-02206-6. Epub 2022 Jan 28.

Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.

Front Med (Lausanne). 2021 Mar 15;8:566100. doi: 10.3389/fmed.2021.566100. eCollection 2021.

Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.

Am J Case Rep. 2021 Jan 14;22:e927137. doi: 10.12659/AJCR.927137.

A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.

Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.

Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides.

J Transl Med. 2017 Dec 11;15(1):247. doi: 10.1186/s12967-017-1351-0.

Extremophilic proteases as novel and efficient tools in short peptide synthesis.

J Ind Microbiol Biotechnol. 2017 Sep;44(9):1325-1342. doi: 10.1007/s10295-017-1961-9. Epub 2017 Jun 23.

Hereditary angioedema: what the gastroenterologist needs to know.

Clin Exp Gastroenterol. 2014 Nov 20;7:435-45. doi: 10.2147/CEG.S50465. eCollection 2014.

Novel targets and regulatory ordeal by QT interval.

Br J Clin Pharmacol. 2010 Apr;69(4):325-8. doi: 10.1111/j.1365-2125.2010.03657.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Icatibant.

Br J Clin Pharmacol. 2010 May;69(5):425-6. doi: 10.1111/j.1365-2125.2010.03642.x.

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73. doi: 10.1177/039463201202500130.

Hereditary angioedema--therapies old and new.

N Engl J Med. 2010 Aug 5;363(6):581-3. doi: 10.1056/NEJMe1006450.

Therapeutic agents for hereditary angioedema.

N Engl J Med. 2011 Jan 6;364(1):85; author reply 86. doi: 10.1056/NEJMc1010085.

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.

J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1671-1678.e2. doi: 10.1016/j.jaip.2017.04.010. Epub 2017 Jun 7.

Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.

Immun Inflamm Dis. 2017 Jan 11;5(1):29-36. doi: 10.1002/iid3.137. eCollection 2017 Mar.

Icatibant as acute treatment for hereditary angioedema in adults.

Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13.

Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.

Ann Allergy Asthma Immunol. 2016 May;116(5):476-7. doi: 10.1016/j.anai.2016.03.008. Epub 2016 Mar 24.

Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.

Dermatol Ther. 2019 Nov;32(6):e13098. doi: 10.1111/dth.13098. Epub 2019 Oct 28.

First report of icatibant treatment in a pregnant patient with hereditary angioedema.

J Obstet Gynaecol Res. 2016 Aug;42(8):1026-8. doi: 10.1111/jog.13003. Epub 2016 Apr 19.

引用本文的文献

A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema.

J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):721-734. doi: 10.1007/s10928-024-09919-6. Epub 2024 May 11.

Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.

Naunyn Schmiedebergs Arch Pharmacol. 2022 Mar;395(3):275-283. doi: 10.1007/s00210-022-02206-6. Epub 2022 Jan 28.

Case Report: Post-operative Angioedema After a Laryngeal Mask Airway Application.

Front Med (Lausanne). 2021 Mar 15;8:566100. doi: 10.3389/fmed.2021.566100. eCollection 2021.

Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.

Am J Case Rep. 2021 Jan 14;22:e927137. doi: 10.12659/AJCR.927137.

A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.

Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.

Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides.

J Transl Med. 2017 Dec 11;15(1):247. doi: 10.1186/s12967-017-1351-0.

Extremophilic proteases as novel and efficient tools in short peptide synthesis.

J Ind Microbiol Biotechnol. 2017 Sep;44(9):1325-1342. doi: 10.1007/s10295-017-1961-9. Epub 2017 Jun 23.

Hereditary angioedema: what the gastroenterologist needs to know.

Clin Exp Gastroenterol. 2014 Nov 20;7:435-45. doi: 10.2147/CEG.S50465. eCollection 2014.

Novel targets and regulatory ordeal by QT interval.

Br J Clin Pharmacol. 2010 Apr;69(4):325-8. doi: 10.1111/j.1365-2125.2010.03657.x.